https://www.selleckchem.com/pr....oducts/Vorinostat-sa
4% of total costs. Reliable estimates of the cost burden of HAI management are important for assessing the cost-effectiveness of IPC programmes. This unique study presents robust economic data, demonstrating that HAI remains a burden to the UK NHS and bed-days capture the majority of inpatient costs. These findings can be used to inform the economic evaluation and decision analytic modelling of competing IPC programmes at local and national level. Reliable estimates of the cost burden of HAI management are important for assessin
Curtir
Comentario
Compartilhar
